Design and evaluation of polymeric ocular drug delivery system for controlled delivery of moxifloxacin hydrochloride: In vitro and in vivo evaluation

Acta Pharmaceutica Sciencia

Volumn 52, Issue 4, 2010, Pages 522-534

  Patel, U L ^a   Chotai, N P ^b   Nagda, C D ^c  

^a Arihant School of Pharmacy and Bioresearch Institute   (India)

^b AR Patel and GH Patel Institute of Pharmacy   (India)

^c Indukaka Ipcowala College of Pharmacy   (India)

Author keywords

Cross linking; Gelatin; In vitro and in vivo release; Moxifloxacin hydrochloride; Ocular insert; References

Indexed keywords

GELATIN; MOXIFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; EXCIPIENT COMPATIBILITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; NONHUMAN; PH MEASUREMENT; PHYSICAL CHEMISTRY; THICKNESS; WATER ABSORPTION;

EID: 79952304087     PISSN: 13072080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ali, M., Iqbal, M. and Rao, K.S. (2009). Evaluation of progesterone loaded glutraldehyde cross-linked chitosan implants. The Indian Pharmacist. 79: 95-98.
2. Barbu, E., Sarvaiya, I., Green, K.L., Nevel, T.G. and Tsibouk, J. (2005). Vinylpyrrolidone-co- (meth) acrylic acid insert for ocular drug delivery: synthesis and evaluation. J Biomed Mater Res. 74: 343-349.
3. Brian, R., Matthews, G. and Michael, W. (2000). Stability storage and testing of ophthalmic products for global registration. Drug. Dev. Ind. Pharm.26: 1227-1237.
4. Chari, S.S., Makoid, M.C., Erikson, S.P. and Robinson, J.R.(1974). Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J. Pharm. Sci. 64: 333.
5. Charoo, N.A., Kohli, K., Ali, A. and Anwer, A. (2003). Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies. Drug. Dev. Ind. Pharm. 29: 215-221.
6. Costa, P. and Sousa Lobo, J.M. (2001). Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences. 13:123-133.
7. Draize, J.H., Woodward, G. and Calvery, H.O. (1944). Methods for the study of irritation and toxicity of substance applied topically to the skin and mucous membrane. J Pharmacol Exp Ther. 82: 377-390.
8. Eduardo, A. and Crider, J. (2005). Ophthalmic infections and their anti-infective challenges. Surv. Ophthalmol. 50 (supp l): S1-S6.
9. Gupta, A., Sharma, S.K. and Ahuja, M. (2007). In vitro and in vivo evaluation of gellan based ocular inserts of phenylephrine. Acta Pharm. Sci. 49: 55-63.
10. Harishkumar, S.L., Balasubramaniaum, J. and Kumar, M.T. (2004). In vitro characterization of physically reinforced ocular inserts of Indomethacin. Acta Pharmaceutica Turcica. 46: 17-24.
11. Jain, S.K., Chourasia, M.K., Jain, A.K. and Jain, R.K. (2004). Microspheres bearing salbutamol for nasal delivery. Drug Del. 11: 113-122.
12. Karatas, A. and Baykara, T. (2001). Studies on Indomethacin insert prepared by water soluble polymers: The relation between dissolution rate and swelling behavior. Il farmaco. 56:197-202.
13. Khan, S., Ali, A., Singhavi, D. and Pramod, Y. (2008). Controlled ocular delivery of acyclovir trough rate controlling ocular insert of eudragit: A technical note. AAPS PharmSciTech. 9:169-172.
14. Mishra, D.N. and Gilhotra, R.M. (2008). Development studies on gel-forming erodible ocular polymeric films of Gatifloxacin sesquehydrate. Acta Pharmaceutica Sciencia. 50:145-152.
15. Mundada, A.S. and Shrikhande, B.K. (2006). Design and evaluation of soluble ophthalmic insert for controlled release of ciprofloxacin hydrochloride. Drug. Dev. Ind. Pharm. 32:443-448.
16. Mundada, A. and Shrikhande, B.K. (2008). Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular insert. Current Eye Research. 33:469-475.
17. Murthy, S.N. (1997). Biodegradable polymers matrix based ocuserts of diclofenac sodium. Indian Drugs. 34: 336-338.
18. OECD guideline (2002). Acute eye irritation/corrosion, test guideline 405.
19. Ostergaard, C. and Sorensen, J.D. (1998). Moller NF. Antimicrob.agents Chemother. 42:1706.
20. Patel, U., Chaudhary, K.A., Chotai, N.P. and Chirag, N.(2008). Formulation and evaluation of indomethacin ophthalmic inserts. Indian J. Pharm. Educ. Res. 42:348-352.
21. Sankar, V., Chandrasekaran, A.K., Durga, S., Geetha, G. and Ravichandran, V.A. (2006). Design and evaluation of diclofenac sodium ophthalmic inserts. Acta Pharmaceutica Sciencia. 48: 5-10.
22. Semalty, M., Semalty, A. and Kumar, G. (2008). Formulation and characterization of mucoadhesive buccal film of glipizide. Indian J. Pharma. Sci. 70: 61-65.
23. Sreenivas, S.A., Hiremanth, S.P. and Godbole, A.M. (2006). Ofloxacin ocular inserts: Design, formulation and evaluation. IJPT. 5:159-162.
24. Sultana, Y., Aquil, M. and Ali, A. (2005). Ocular insert for controlled delivery of pefloxacin mesylate: preparation and evaluation. Acta Pharma. 55: 305-314.
25. Trindade, M.A.G., Cunha, P.A.C. and Araujo, T.A. (2006). Interaction study of moxifloxacin with Cu(II) ion using square-wave voltammetry and its application in the determination in tablets. Ecl.Quim. 31:31-38.
26. Vijayendra, S.M., Nanjawade, B.K. and Manvi, F.V. (2006). Development of sustained ocular drug delivery system for betaxolol. Indian J. Pharm. Educ. Res. 40:165-168.